SWOG clinical trial number
SWOG-8300

Treatment of Limited Non-Small Cell Lung Cancer: Radiation Versus Radiation Plus Chemotherapy (FOMi/CAP)

Closed
Phase
Published
Abbreviated Title
Treatment of Limited Non-Small Cell Lung Cancer: Radiation Versus Radiation Plus Chemotherapy (FOMi/CAP)
Activated
07/20/1984
Closed
03/01/1988

Research committees

Lung Cancer

Publication Information Expand/Collapse

2005

Southwest Oncology Group: Two decades of experience in non-small cell lung cancer

AT Turrisi;J Crowley;K Albain;L Gaspar;D Gandara Seminars in Oncology 32(2Suppl3):S119-S121

PMid: PMID16015548

2002

Factorial design considerations

S Green;PY Liu;J O'Sullivan Journal of Clinical Oncology 20(16):3424-3430

1998

A randomized trial of chemotherapy and Radiotherapy for stage III non-small cell lung cancer.

TP Miller;JJ Crowley;JG Mira;JG Schwartz;L Hutchins;L Baker;R Natale;EM Chase;RB Livingston Cancer Therapeutics 1(4):229-236

Other Clinical Trials

SWOG Clinical Trial Number
A082302

EVALUATING ADJUVANT ATEZOLIZUMAB OR ATEZOLIZUMAB AND HYALURONIDASE-TQJS TO PREVENT RECURRENCE IN STAGE I NON-SMALL CELL LUNG CANCER (NSCLC): A RANDOMIZED PHASE III TRIAL (AASI-NSCLC)
Research Committee(s)
Lung Cancer
Activated
03/02/2027
Open
SWOG Clinical Trial Number
S2409

PRISM: PRecIsion in SCLC via a Multicohort Study: Randomized Phase II studies evaluating maintenance Durvalumab with or without Biomarker-Directed Therapy for Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Research Committee(s)
Lung Cancer
Activated
09/08/2025
Accrual
2%
Open
Phase
SWOG Clinical Trial Number
CTSU/EA5231

A Randomized Phase III Trial of Checkpoint Blockade in Lung Cance3r Patients in the Adjuvant Setting Based on Pathologic Response Following Neoadjuvant Therapy (CLEAR)
Research Committee(s)
Lung Cancer
Activated
06/13/2025
Open
Phase